Results for tag: "Omalizumab"

Omalizumab is a monoclonal antibody used to treat severe allergic asthma and chronic idiopathic urticaria. It works by blocking the action of immunoglobulin E (IgE), a type of antibody that plays a role in allergic reactions. Omalizumab is administered as an injection and is approved for use in adults and children over 12 years of age. It is used to reduce the frequency and severity of asthma attacks, as well as to reduce the need for other asthma medications. It is also used to reduce the frequency and severity of hives in people with chronic idiopathic urticaria. Omalizumab is a relatively new drug, having been approved by the US Food and Drug Administration in 2003. It is marketed by several pharmaceutical companies, including Genentech, Novartis, and Sanofi. It is also available as a generic drug in some countries. Omalizumab is a costly drug, but it has been shown to be effective in reducing the symptoms of severe allergic asthma and chronic idiopathic urticaria. Show Less Read more